Статті в журналах з теми "Hormonal therapy (HT)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Hormonal therapy (HT)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Mainar, Laura Baquedano, Leyre Ruiz Campo, Alberto Lanzon Laga, and Miguel Angel Ruiz Conde. "Endometrial cancer and hormonal therapy (HT)." Maturitas 81, no. 1 (May 2015): 198. http://dx.doi.org/10.1016/j.maturitas.2015.02.286.
Повний текст джерелаMizowaki, T., Y. Norihisa, M. Ogura, T. Kamba, T. Inoue, Y. Shimizu, O. Ogawa, and M. Hiraoka. "Survival outcomes of neoadjuvant hormone therapy plus external-beam radiotherapy with relatively early initiation of salvage hormone therapy to patients with T3-4N0M0 prostate cancer." Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 95. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.95.
Повний текст джерелаWagner, Lynne I., Robert James Gray, George W. Sledge, Timothy Joseph Whelan, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, David Cella, and Joseph Sparano. "Patient-reported cognitive impairments among women with breast cancer randomly assigned to hormonal therapy (HT) alone versus chemotherapy followed by hormonal therapy (C+HT): Results from the Trial Assigning Individualized Options for Treatment (TAILORx)." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 9020. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9020.
Повний текст джерелаLam, Lydia, Kenji Inaba, Bernardino Castelo Branco, Bradley Putty, Ali Salim, Donald J. Green, Peep Talving, and Demetrios Demetriades. "The Impact of Early Hormonal Therapy in Catastrophic Brain-Injured Patients and Its Effect on Organ Procurement." American Surgeon 78, no. 3 (March 2012): 318–24. http://dx.doi.org/10.1177/000313481207800340.
Повний текст джерелаAizawa, Rihito, Kenji Takayama, Kiyonao Nakamura, Takahiro Inoue, Takashi Kobayashi, Shusuke Akamatsu, Toshinari Yamasaki, Osamu Ogawa, and Takashi Mizowaki. "Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for Japanese patients with non-metastatic prostate cancer." Journal of Clinical Oncology 36, no. 6_suppl (February 20, 2018): 49. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.49.
Повний текст джерелаFlanagan, J. R., C. Carney-Doebbeling, L. Jones, and C. Sweeney. "Metabolic syndrome predicts for shorter response to hormonal therapy in prostate cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 4554. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4554.
Повний текст джерелаAberbach, Irit, Liliana Schliamser, Zeev Blumenfeld, Benjamin Brenner, and Galit Sarig. "Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy." Thrombosis and Haemostasis 96, no. 11 (2006): 578–83. http://dx.doi.org/10.1160/th06-05-0285.
Повний текст джерелаOlufade, Temitope O., Karen E. Skinner, Nicola Di Santo, Rahul A. Shenolikar, Mark Stephen Walker, and Lee Steven Schwartzberg. "Real-world effectiveness of fulvestrant monotherapy as first hormonal therapy in metastatic breast cancer patients." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e12537-e12537. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12537.
Повний текст джерелаLin, Jenny J., Kathie-Ann P. Joseph, Kezhen Fei, Rebeca Franco, and Nina Bickell. "Adherence to hormone treatment for breast cancer and beliefs about treatment and screening." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e11004-e11004. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e11004.
Повний текст джерелаMilitello, Loredana, Paolo Carli, Vincenzo Di Lauro, Simon Spazzapan, Simona Scalone, Davide Lombardi, Alessandro Tuzi, et al. "Bevacizumab as maintenance therapy (mBev) in metastatic breast cancer (MBC)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e22149-e22149. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e22149.
Повний текст джерелаDavis, S. R., I. Dinatale, L. Rivera-Woll, and S. Davison. "Postmenopausal hormone therapy: from monkey glands to transdermal patches." Journal of Endocrinology 185, no. 2 (May 2005): 207–22. http://dx.doi.org/10.1677/joe.1.05847.
Повний текст джерелаAhmed, Mohamed E., Jack R. Andrews, Ayca Dundar, Masaya Jimbo, Vidhu B. Joshi, Giovanni Motterle, Jeffrey Karnes, et al. "Non-rising PSA disease progression on C-11 choline PET/CT imaging in patients receiving second generation hormone therapies (2nd-HT)." Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020): 144. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.144.
Повний текст джерелаNanda, Akash, Ming-Hui Chen, Brian Joseph Moran, Michelle H. Braccioforte, and Anthony Victor D'Amico. "Intermediate versus short-course hormone therapy and mortality in men with high-risk prostate cancer treated with radiation therapy." Journal of Clinical Oncology 31, no. 6_suppl (February 20, 2013): 83. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.83.
Повний текст джерелаIsmael, G., A. L. Coradazzi, C. A. Beato, P. Milhomem, J. Oliveira, C. Manzoni, and G. Segalla. "Adjuvant systemic therapy in elderly patients with breast cancer: A Brazilian single center experience." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e20711-e20711. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e20711.
Повний текст джерелаQuon, H. C., P. Cheung, D. A. Loblaw, G. Morton, E. Szumacher, C. Danjoux, R. Choo, G. Thomas, A. Kiss, and A. Deabreu. "Quality of life after pelvic radiotherapy with hypofractionated IMRT boost and long-term hormone therapy for locally advanced prostate cancer." Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 75. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.75.
Повний текст джерелаAngelergues, Antoine, Denis Maillet, Aude Flechon, Mustafa Ozguroglu, Florence Mercier, Aline Guillot, Sylvestre Le Moulec, et al. "Duration of response to androgen-deprivation therapy (ADT) and efficacy of secondary hormone therapy, docetaxel (D), and cabazitaxel (C) in metastatic castration-resistant prostate cancer (mCRPC)." Journal of Clinical Oncology 32, no. 4_suppl (February 1, 2014): 282. http://dx.doi.org/10.1200/jco.2014.32.4_suppl.282.
Повний текст джерелаTsai, Chi-Jui, Ho-Yin Huang, Fang-Ming Chen, Yi-Hsin Yang, Li-Chia Chen, and Kun-Pin Hsieh. "Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ." PLOS ONE 17, no. 1 (January 28, 2022): e0262934. http://dx.doi.org/10.1371/journal.pone.0262934.
Повний текст джерелаBartelink, H., R. D. Rubens, E. van der Schueren, and R. Sylvester. "Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial." Journal of Clinical Oncology 15, no. 1 (January 1997): 207–15. http://dx.doi.org/10.1200/jco.1997.15.1.207.
Повний текст джерелаSella, Tal, and Gabriel Chodick. "Adherence and Persistence to Adjuvant Hormonal Therapy in Early-Stage Breast Cancer Patients: A Population-Based Retrospective Cohort Study in Israel." Breast Care 15, no. 1 (May 29, 2019): 45–54. http://dx.doi.org/10.1159/000500318.
Повний текст джерелаJamy, Omer HASSAN, Namratha Reddy Vontela, Justin Gatwood, Mark Stephen Walker, Edward J. Stepanski, and Gregory A. Vidal. "Using patient-reported outcomes to assess the effectiveness of topical hormonal replacement therapy (THR) for vaginal complaints (VC) after anti-hormonal therapy (HT) treatment for breast cancer (BC)." Journal of Clinical Oncology 34, no. 26_suppl (October 9, 2016): 77. http://dx.doi.org/10.1200/jco.2016.34.26_suppl.77.
Повний текст джерелаSpain, Pamela, Stephanie Teixeira-Poit, Michael T. Halpern, Kathleen Castro, Irene Prabhu Das, Brenda A. Adjei, and Steven Clauser. "NCI Community Cancer Center Program (NCCCP): Understanding why hormonal therapy for breast cancer was considered but not administered." Journal of Clinical Oncology 34, no. 7_suppl (March 1, 2016): 74. http://dx.doi.org/10.1200/jco.2016.34.7_suppl.74.
Повний текст джерелаLee, Anna, Daniel J. Becker, Ariel J. Lederman, Virginia W. Osborn, Meng S. Shao, Andrew T. Wong, David Schwartz, and David Schreiber. "Comparison of Neoadjuvant vs Concurrent/Adjuvant Androgen Deprivation in Men with High-risk Prostate Cancer Receiving Definitive Radiation Therapy." Tumori Journal 103, no. 4 (July 2017): 387–93. http://dx.doi.org/10.5301/tj.5000595.
Повний текст джерелаLoeb, Stacy, Meike Adam, Pierre Tennstedt, Wolfgang Huber, Juergen Bernard, Derya Tilki, Markus Graefen, Hartwig Huland, and Thorsten Schlomm. "Toxicity in a multimodality approach of radical prostatectomy with radiation and hormonal therapy." Journal of Clinical Oncology 34, no. 2_suppl (January 10, 2016): 107. http://dx.doi.org/10.1200/jco.2016.34.2_suppl.107.
Повний текст джерелаGartrell, Benjamin Adam, Giuseppe Del Priore, Avi S. Retter, Wen-Tien Chen, Gerald H. Sokol, Alexander G. Vandell, and Mack Roach. "Evaluating non-hormonal therapy in a phase II trial of SM-88 for rising PSA prostate cancer." Journal of Clinical Oncology 37, no. 7_suppl (March 1, 2019): 83. http://dx.doi.org/10.1200/jco.2019.37.7_suppl.83.
Повний текст джерелаJerusalem, Guy Heinrich Maria, Patrick Neven, Nina Marinsek, Jie Zhang, Ravi Degun, Giancarlo Benelli, Stephen Saletan, and Fabrice Andre. "Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) in Europe." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e17520-e17520. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e17520.
Повний текст джерелаSitruk-Ware, Regine. "Progestins in hormonal therapy (HT) today, tomorrow and the next day: a roundtable discussion." Steroids 68, no. 10-13 (November 2003): 973–79. http://dx.doi.org/10.1016/j.steroids.2003.08.004.
Повний текст джерелаSansone, Pasquale, Claudia Savini, Ivana Kurelac, Qing Chang, Laura Benedetta Amato, Antonio Strillacci, Anna Stepanova, et al. "Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer." Proceedings of the National Academy of Sciences 114, no. 43 (October 11, 2017): E9066—E9075. http://dx.doi.org/10.1073/pnas.1704862114.
Повний текст джерелаBarata, Pedro C., Hamid Emamekhoo, Prateek Mendiratta, Dharmesh Gopalakrishnan, Vadim S. Koshkin, Allison Janine Tyler, Moshe Chaim Ornstein, et al. "Treatment patterns for metastatic hormone-sensitive prostate cancer (mHSPC) progressing after up-front docetaxel in combination with androgen deprivation therapy (D-ADT)." Journal of Clinical Oncology 36, no. 6_suppl (February 20, 2018): 305. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.305.
Повний текст джерелаTassinari, Roberta, and Francesca Maranghi. "Rodent Model of Gender-Affirming Hormone Therapies as Specific Tool for Identifying Susceptibility and Vulnerability of Transgender People and Future Applications for Risk Assessment." International Journal of Environmental Research and Public Health 18, no. 23 (November 30, 2021): 12640. http://dx.doi.org/10.3390/ijerph182312640.
Повний текст джерелаSantoro, Nanette, Cassandra Roeca, Brandilyn A. Peters, and Genevieve Neal-Perry. "The Menopause Transition: Signs, Symptoms, and Management Options." Journal of Clinical Endocrinology & Metabolism 106, no. 1 (October 23, 2020): 1–15. http://dx.doi.org/10.1210/clinem/dgaa764.
Повний текст джерелаSymmans, William Fraser, Eleni Andreopoulou, Daniel J. Booser, Christos Hatzis, Michael J. Wallace, Ya Zhang, Yun Gong, et al. "Progression of genomic signatures in local and metastatic estrogen receptor-positive (ER+) breast cancer: Relevance to palliative treatment." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 515. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.515.
Повний текст джерелаMoleti, Mariacarla, Maria Di Mauro, Angela Alibrandi, Roberto Vita, Salvatore Benvenga, and Francesco Vermiglio. "Postpartum Thyroiditis in Women With Euthyroid and Hypothyroid Hashimoto’s Thyroiditis Antedating Pregnancy." Journal of Clinical Endocrinology & Metabolism 105, no. 7 (April 17, 2020): e2421-e2428. http://dx.doi.org/10.1210/clinem/dgaa197.
Повний текст джерелаAl-Saleh, Khalid A., Adda Bounedjar, Mohammed Oukkal, Hasen Mahfouf, Kamel Bouzid, Assia Bensalem, Prof Taha Fillali, et al. "Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 594. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.594.
Повний текст джерелаSafronova, E. Yu, A. A. Krasheninnikov, S. A. Sergienko, and A. A. Kostin. "THE USE OF MODERN ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN THE HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER." Research'n Practical Medicine Journal 4, no. 2 (June 17, 2017): 23–28. http://dx.doi.org/10.17709/2409-2231-2017-4-2-3.
Повний текст джерелаPortokalidou, Zoi, Anna Huysse-Gaytandjieva, and Madelon L. Peters. "Experiences of Patients With Hashimoto Thyroiditis Through the Lens of Compassion." OBM Integrative and Complementary Medicine 7, no. 3 (January 9, 2022): 1. http://dx.doi.org/10.21926/obm.icm.2203027.
Повний текст джерелаAbdul Sater, Houssein Talal, Ramses F. Sadek, Li fang Zhang, Aaron Gopal, Jean-Pierre Blaize, David Yashar, Reena Patel, Swetha Aribindi, Hiral S. Patel, and Shou-Ching Tang. "Validity of 1% hormonal positivity cutoff by American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines at Georgia Cancer Center." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 1094. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1094.
Повний текст джерелаGoy, Barry W., and In-Lu Amy Liu. "Redefining the role of adjuvant versus salvage radiation therapy for prostate cancer after radical prostatectomy for T3 disease and/or positive margins." Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020): 367. http://dx.doi.org/10.1200/jco.2020.38.6_suppl.367.
Повний текст джерелаJerez, Jose Manuel, Nuria Ribelles, Pablo Rodriguez-Brazzarola, Tamara Diaz Redondo, Begoña Jimenez Rodriguez, Alfonso Sanchez-Muñoz, Antonia Marquez, et al. "Prediction of early progression (EP) to CDKIs first line treatment in ER+/HER2- metastatic breast cancer (MBC) using machine learning." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13040-e13040. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13040.
Повний текст джерелаPalomares, Melanie R., Michelle Banzet, Kelley Lu, Jacob Justus, Rebecca A. Ottesen, and Joyce C. Niland. "Breast cancer risk reduction among patients with DCIS." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 1562. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1562.
Повний текст джерелаLadha, Abdullah, and Josy Mathew. "Risk factors for fractures in patients on hormonal therapies for breast cancer and DCIS." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e19627-e19627. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e19627.
Повний текст джерелаKling, Juliana M., N. Maritza Dowling, Heather A. Bimonte-Nelson, Carey E. Gleason, Kejal Kantarci, JoAnn E. Manson, Hugh S. Taylor, et al. "Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 317, no. 6 (December 1, 2019): R912—R920. http://dx.doi.org/10.1152/ajpregu.00234.2019.
Повний текст джерелаSchelbaum, Eva, Lacey Loughlin, Steven Jett, Cenai Zhang, Grace Jang, Niharika Malviya, Hollie Hristov, et al. "Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife." Neurology 97, no. 23 (November 3, 2021): e2328-e2339. http://dx.doi.org/10.1212/wnl.0000000000012941.
Повний текст джерелаMeyer, Nicole, Yanni Hao, Xue Song, Nianwen Shi, William Johnson, Jaqueline Willemann Rogerio, and Denise A. Yardley. "Healthcare Resource Use and Expenditures among Metastatic Breast Cancer Patients Treated with HER2-Targeted Agents." International Journal of Breast Cancer 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/475171.
Повний текст джерелаAggarwal, Sangeeta, Mingfeng Liu, Rishi Sharma, Fred Yang, Ankit Gupta, Divjot Singh, Rahul Sharma, Anirban Basak, and Alok Aggarwal. "Voice of Cancer Patients: Analysis of patient concerns regarding cognitive deficits associated with treatment for breast cancer." Journal of Clinical Oncology 33, no. 28_suppl (October 1, 2015): 82. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.82.
Повний текст джерелаBove, Riley, Liene Elsone, Enrique Alvarez, Nadja Borisow, Melissa M. Cortez, Farrah J. Mateen, Maureen A. Mealy, et al. "Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study." Neurology - Neuroimmunology Neuroinflammation 4, no. 3 (March 24, 2017): e339. http://dx.doi.org/10.1212/nxi.0000000000000339.
Повний текст джерелаRavnik, M., A. Sadikov, N. Snoj, P. Nussdorfer, and T. Cufer. "Validation of Adjuvant!Online on Slovenian collective of early breast cancer patients." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): e11532-e11532. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e11532.
Повний текст джерелаSinibaldi, V. J., M. A. Carducci, K. Elza-Brown, E. Rosenbaum, S. Denmeade, R. Pili, J. Walczak, E. Garrett-Mayer, S. Moore-Cooper, and M. A. Eisenberger. "A phase II evaluation of imatinib mesylate (G) in stage M0 prostate cancer (PC) patients (pts) on hormonal therapy (HT) with evidence of biochemical relapse." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 14612. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.14612.
Повний текст джерелаMason, Jeremy, Yutao Gong, Laleh Amiri-Kordestani, Suparna Wedam, Jennifer J. Gao, Tatiana M. Prowell, Harpreet Singh, et al. "Model Development of CDK4/6 Predicted Efficacy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer." JCO Clinical Cancer Informatics, no. 5 (June 2021): 758–67. http://dx.doi.org/10.1200/cci.21.00025.
Повний текст джерелаMattar, André, Guilherme R. Fonseca, Murilo B. A. Romão, Jorge Y. Shida, Vilmar M. de Oliveira, Maria C. S. Bastos, Fabio Bagnoli, et al. "Substantial Reduction in Adjuvant Chemotherapy With the Use of the 21-Gene Test to Manage Early Breast Cancer in a Public Hospital in Brazil." JCO Global Oncology, no. 7 (July 2021): 1003–11. http://dx.doi.org/10.1200/go.20.00609.
Повний текст джерелаEllis, Peter G., Adam M. Brufsky, Sushil Beriwal, Kathleen G. Lokay, Hans O. Benson, Stephanie B. McCutcheon, and Melinda Krebs. "Pathways Clinical Decision Support for Appropriate Use of Key Biomarkers." Journal of Oncology Practice 12, no. 6 (June 2016): e681-e687. http://dx.doi.org/10.1200/jop.2015.010546.
Повний текст джерела